Dr. Jesus Mendiolaza, MD

Dr. Mendiolaza practices at Centerwell Senior Primary Care of West Vine in Kissimmee, Florida.

Dr. Mendiolaza's NPI, 1437294881, was assigned on February 21, 2007. Dr. Mendiolaza graduated from National University of Federico Villarreal Faculty of Medicine in 1994. Dr. Mendiolaza's Wisconsin license number on file is 3800.

Dr. Mendiolaza's primary practice is Centerwell Senior Primary Care of West Vine, at 3185 W Vine St, Kissimmee, FL 34741 in Osceola County. The practice phone is (407) 569-1260.

Dr. Mendiolaza's primary practice is Centerwell Senior Primary Care of West Vine in Kissimmee, Florida. The medical group on file is CenterWell Senior Primary Care. Dmand AI also links Dr. Mendiolaza to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendiolaza practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mendiolaza's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mendiolaza is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mendiolaza's licenses on file in 15 states: Wisconsin, Florida, Ohio, Arizona, Georgia, Illinois, Utah, Alabama, Colorado, Connecticut, Delaware, Maryland, Tennessee, Texas and Washington.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT), endocarditis, intermittent racing heartbeat (PSVT) and muscle disease among the conditions Dr. Mendiolaza treats.

CMS data shows 1,480 Medicare services from Dr. Mendiolaza across 18 procedure codes in 2024, for 952 Medicare patients. Medicare paid $50,087 for them.

CMS counts 952 Medicare patients who saw Dr. Mendiolaza in 2024. The largest group is 65 to 74, with 445 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mendiolaza's median patient age at 74, with 52% women.

In 2024, Dr. Mendiolaza wrote 954 Medicare Part D claims for 228 patients. 73% of them were for generic drugs. CMS names the drug for 830 of them, across 19 drugs with 11 or more claims each, at $190,694 in total drug cost. In 2023, CMS named 264 claims across 12 drugs.

Dr. Mendiolaza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mendiolaza as offering telehealth.

Dmand AI links 1 paper to Dr. Mendiolaza. Dr. Mendiolaza's most frequent co-author is Paulo Bandeira Pinho, MD.

CMS Open Payments shows 277 general payments to Dr. Mendiolaza from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,081.

Dmand AI lists 2 awards for Dr. Mendiolaza, most recently CMS Stage 1 EHR in 2013.

Dr. Mendiolaza graduated from National University of Federico Villarreal Faculty of Medicine in 1994. Dr. Mendiolaza is a member of ACC.

Dr. Mendiolaza is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.